2017 China BioMed Innovation and Investment Conference (2017 CBIIC) is co-hosted by Securities Association of China (SAC), China Pharmaceutical Innovation and Research Development Association (PhIRDA) and China Association for Medical Devices Industry (CAMDI) on October 29-31 in Suzhou Industrial Park.
Under the theme of “Promote the Linkage between Social Capital and Pharmaceutical Innovation, Improve Innovation Capability of Pharmaceutical Industry”, 2017 CBIIC will showcase biotechnology companies, academic institutions, state biotechnology centers, investment funds in China, as well as innovated drug development companies in the US and Australia, Asia, Europe and Canada.
The 2017 CBIIC conference will feature keynotes and sessions from key policymakers, KOLs from investment institutions and pharmaceutical industry discussing about the trend of new drug research and development and investment in the field of pharmaceutical.
Vice Director of National Health and Family Planning Commission
CFDA Vice Minister
Director-General of Division of Health Science, Technology and Education of NHFPC
Deputy Director-General of Department of Drug and Cosmetics Registration of CFDA
Deputy Director of CDE, CFDA
Chairman and CEO of Betta Pharmaceuticals Co., Ltd.
Executive Vice - Chairman of Organizing Committee
Executive Chairman of Organizing Committee
Executive Vice Chairman of Organizing Committee
Chairman of JPMorgan Chase International
Ph.D., CEO of Institute for Biotechnology and Medicine Industry (IBMI)
Hong Kong Biotechnology Organization
Director of International Association of Quality Research in Chinese Medicine（Macau）
Chairman of the Board of NFCR
Founding Partner of Shenzhen Qianhai YuanMing Asset Management Co., Ltd.
Managing Director and Head of Project Management, Market Development, HKEX
Senior Vice President,Issuer Services, Market Development Division, Hong Kong Exchanges and Clearing Ltd.
Chairman of Asia Pacific Investment Banking, J.P. Morgan
Chairman & Chief Executive Officer，Zai Lab Limited
he vice president of China Galaxy Securities and chairman of the Galaxy Jinhui Securities Asset Management Co., Ltd.
Chairman & CEO, GL Capital Group
Jacobio Pharmaceuticals Chairman and ETown-Jacobio Biocapital’s chairman
Co-Founder，President & COO of Tesaro Co., Ltd.
Cardiology Director of Pecking University First Hospital
Director of clinical laboratory diagnosis of Beijing Tiantan Hospital
Chairman of the Board & CEO Innovent Biologics（Suzhou）Co.,Ltd
Co-founder and CEO of Hua Medicine (Shanghai) Ltd.
Zhejiang DTRM Biopharma LLC Inventor，Founder & CEO
Associate Professor of Peking University Cancer Hospital
Dept. of glioma, Beijing Shijitan Hospital,Capital Medical University, Beijing
The Board chairman & CEO of HEP Pharma
PhD, MBA, Founder, Chairman and CEO of CANbridge, Distinguished Expert for “the Thousand Talents Plan”
MD, PhD ,CStone Pharmaceuticals CEO
Henan Provincial Tumor Hospital The lung cancer treatment center in Henan Province Doctor of Oncology, Deputy Chief Physician, Master Instructor
Associate chief physician of Kidney cancer and melanoma internal medicine Department，Peking University Cancer Hospital
Chief Medical Officer, China, Teclison Limited
Co-Founder and CEO of OnvoVent
VP of KBP and President of KBP China
TF SECURITIES Senior analyst
Investment director，Beijing Shunxi Equity Investment Fund Management Co. Ltd.
Secretary of the board of directors of Yantai Zhenghai Bio-tech Co., Ltd.
President,Ping An Bank,Finance SBU of Healthcare, Culture &Tourism Industries
Head of Healthcare Group, Chief Analyst, SHENWAN HONGYUAN SECURITIES
Executive Director of Goldman
Managing Partner at LYZZ Capital
The Pharmaceutical Industry Chief Analyst of TF Securities
Managing Director in Research Department， China International Capital Corporation
Senior analyst at CITIC Securities pharmaceutical industry, senior vice President of research department
President and COO of NFCR
Chairman and CEO Ascentage Pharma
Managing Director of J.P. Morgan Healthcare Investment Banking Group
Trade Commissioner, Australian Trade and Investment Commission Guangzhou Commercial Consul, Australian Consulate-General Guangzhou
Vice-Consul and Trade Commissioner at Consulate General of Canada in Shanghai
Senior Trade Commissioner of Austrade Shanghai
Executive Vice President and Chief Business Officer and Chief Strategy Officer of WuXi AppTec.
Serica Capital Managing Partner
BOHE Angel Fund
TF Capital CEO
Managing Partner Jianxin RunKang Capital and Founding Partner of Manhattan Capital Group
Executive Chairman of Shenzhen Efung Investment Management Enterprise L.P.
Sequoia Capital Medical Partner
Co-Founder and CEO of JW Therapeutics
Founding partner at Biotrack Capital
Partner, Hillhouse Capital Group
Advantech Capital Partner
Managing Partner of YuanMing Capital
GTJA Investment Group (GIG) EMT member, Managing Partner
Chairman of the board in PharmaSea (Beijing) Biomedical Technology Co., Ltd.
Executive vice President of China pharmaceutical university graduate school
Secretary-general of the Association of “Thousand Talent” Expert
Executive Vice President, Head of Clinical Development and Regulatory Affairs, ZaiLaboratory
Conference Registration Contact
Conference Contact Person
Conference Contact Person